NanoString Technologies, Inc.

About NanoString Technologies, Inc.

NanoString Technologies is dedicated to catalyzing the next biological revolution to improve the human condition through innovative spatial biology solutions. The company focuses on translating scientific discoveries into actionable insights, offering cutting-edge platforms for spatial transcriptomics, proteomics, and genomics to advance research in various disease areas.

Products & Services

nCounter® Analysis System:A system for rapid translation of scientific discoveries into actionable gene expression insights with 800-plex direct digital detection.

GeoMx® Digital Spatial Profiler:Enables spatial profiling of the whole transcriptome and over 570 proteins from FFPE and fresh frozen tissue.

CosMx® Spatial Molecular Imager:Offers high-plex, multiomic, spatial single-cell imaging for deeper insights in cell atlasing, cellular interactions, and biomarker discovery.

CellScape™ Precise Spatial Proteomics:Provides high-plex spatial protein detection and quantitative phenotyping with a flexible workflow.

AtoMx® Spatial Informatics Platform:A platform for spatial informatics to support research data analysis.

CosMx Human Whole Transcriptome Assay:A comprehensive assay for spatial transcriptomics research.

Specialties

Spatial Biology Spatial Transcriptomics Spatial Proteomics Gene Expression Profiling Multiomics Biomarker Discovery Drug Development Oncology Immunology Neuroscience Infectious Disease

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Debt T: - FT: Debt	A: 47500000 MR: - FA: $47.5 million FAN: 47500000	D: 2024-02-09 FD: 2024-02-09	1 investors

Debt Latest

2024-02-09

$47.5M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

L

Leroy Hood

Recent News